CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination with Abiraterone Plus Prednisone in Men with High-Risk Metastatic Hormone-Sensitive Prostate Cancer (Mhspc)
Annals of Oncology（2023）
Key words
Abemaciclib,Metastatic Prostate Cancer,Cell Cycle Control
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined